Search results for "clinical research"

showing 10 items of 474 documents

Periodontal microcirculation in diabetics: An in vivo non-invasive analysis by means of videocapillaroscopy

2012

Summary Background Diabetes mellitus is today considered a society-wide disease of a chronic/degenerative nature. Among the secondary effects of diabetes, the one that interests the dental surgeon most is diabetic parodontopathy. The aim of this study was to underline and objectify microcirculatory variations at a periodontal mucous level in type 2 diabetics. Material/Methods The study enrolled 80 subjects: 40 subjects with a diagnosis of diabetes mellitus type II (18 males and 22 females, between 44 and 85 years of age); and 40 healthy subjects (17 males and 23 females, between 44 and 78 years of age). All the subjects, both diabetic and healthy, were submitted to a videocapillaroscopic ex…

AdultMalePeriodontiummedicine.medical_specialtyperiodontal diseaseDentistryDiseaseMicrocirculationSettore MED/28 - Malattie OdontostomatologicheIn vivoClinical ResearchInternal medicineDiabetes mellitusmedicinemedia_common.cataloged_instanceHumansDental surgeonmedia_commonAgedAged 80 and overbusiness.industryMicrocirculationNon invasiveGeneral MedicinePeriodontiumMiddle Agedmedicine.diseasemicroscopic angioscopyDiabetes Mellitus Type 2mouth mucosaperiodontal microcirculation diabetes videocapillaroscopyFemalebusinessMedical Science Monitor : International Medical Journal of Experimental and Clinical Research
researchProduct

Pharmacokinetics, pharmacodynamics, and safety of moss-aGalactosidase A in patients with Fabry disease.

2019

Moss-aGalactosidase A (moss-aGal) is a moss-derived version of human α-galactosidase developed for enzyme replacement therapy in patients with Fabry disease. It exhibits a homogenous N-glycosylation profile with >90% mannose-terminated glycans. In contrast to mammalian cell produced α-galactosidase, moss-aGal does not rely on mannose-6-phosphate receptor mediated endocytosis but targets the mannose receptor for tissue uptake. We conducted a phase 1 clinical trial with moss-aGal in six patients with confirmed diagnosis of Fabry disease during a 28-day schedule. All patients received a single dose of 0.2 mg/kg moss-aGal by i.v.-infusion. Primary endpoints of the trial were safety and pharmaco…

AdultMalePhases of clinical researchPharmacologyExcretion03 medical and health sciencesPharmacokineticsGermanyGeneticsmedicineHumansEnzyme Replacement TherapyInfusions IntravenousGenetics (clinical)030304 developmental biology0303 health sciencesKidneySphingolipidsbusiness.industry030305 genetics & heredityEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseasemedicine.anatomical_structureTreatment OutcomePharmacodynamicsalpha-GalactosidaseFabry DiseaseFemaleGlycolipidsbusinessMannose receptorJournal of inherited metabolic disease
researchProduct

Soft tissue cell adhesion to titanium abutments after different cleaning procedures: preliminary results of a randomized clinical trial

2013

Objectives: A randomized controlled trial was performed to assess soft tissue cell adhesion to implant titanium abutments subjected to different cleaning procedures and test if plasma cleaning can enhance cell adhesion at an early healing time. Study Design: Eighteen patients with osseointegrated and submerged implants were included. Before re-opening, 18 abutments were divided in 3 groups corresponding to different clinical conditions with different cleaning processes: no treatment (G1), laboratory customization and cleaning by steam (G2), cleaning by plasma of Argon (G3). Abutments were removed after 1 week and scanning electron microscopy was used to analyze cell adhesion to the abutment…

AdultMalePlasma cleaningGingivaAbutmentDentistrychemistry.chemical_elementOdontologíaOsseointegrationDouble-Blind MethodDental AbutmentsConnective tissue dental abutments randomized controlled trial clinical research glow discharged abutment plasma cleaning.Cell AdhesionHumansProspective StudiesCell adhesionGeneral DentistryAgedTitaniumplasma cleaningChemistrybusiness.industryResearchSterilizationSoft tissueMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saluddental abutmentsOtorhinolaryngologyclinical researchglow discharged abutmentrandomized controlled trialUNESCO::CIENCIAS MÉDICASFemaleSurgeryImplantConnective tissuebusinessImplantologyTitanium
researchProduct

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomis…

2017

Summary Background Combined BRAF-MEK inhibitor therapy is the standard of care for BRAF V600 -mutant advanced melanoma. We investigated encorafenib, a BRAF inhibitor with unique target-binding properties, alone or in combination with the MEK inhibitor binimetinib, versus vemurafenib in patients with advanced BRAF V600 -mutant melanoma. Methods COLUMBUS was conducted as a two-part, randomised, open-label phase 3 study at 162 hospitals in 28 countries. Eligible patients were aged 18 years or older and had histologically confirmed locally advanced (American Joint Committee on Cancer [AJCC] stage IIIB, IIIC, or IV), unresectable or metastatic cutaneous melanoma, or unknown primary melanoma; a B…

AdultMaleProto-Oncogene Proteins B-raf0301 basic medicineOncologymedicine.medical_specialtySkin NeoplasmsTime FactorsPhases of clinical researchYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansMolecular Targeted TherapyProgression-free survivalVemurafenibMelanomaProtein Kinase InhibitorsAgedAged 80 and overSulfonamidesPerformance statusbusiness.industryMelanomaMEK inhibitorBinimetinibMiddle Agedmedicine.diseaseProgression-Free Survival030104 developmental biologyVemurafenibOncologyTolerabilitychemistry030220 oncology & carcinogenesisMutationBenzimidazolesFemaleCarbamatesbusinessmedicine.drugThe Lancet Oncology
researchProduct

Liebowitz Social Anxiety Scale (LSAS): Optimal cut points for remission and response in a German sample

2017

The Liebowitz Social Anxiety Scale (LSAS) is the most frequently used instrument to assess social anxiety disorder (SAD) in clinical research and practice. Both a self-reported (LSAS-SR) and a clinician-administered (LSAS-CA) version are available. The aim of the present study was to define optimal cut-off (OC) scores for remission and response to treatment for the LSAS in a German sample. Data of N = 311 patients with SAD were used who had completed psychotherapeutic treatment within a multicentre randomized controlled trial. Diagnosis of SAD and reduction in symptom severity according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 4th editi…

AdultMalePsychometricsLiebowitz social anxiety scaleSensitivity and Specificitylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawGermanyHumansPsychiatric Status Rating ScalesReceiver operating characteristicRemission InductionSocial anxietyNonparametric statisticsReproducibility of ResultsPhobia SocialGold standard (test)030227 psychiatryPsychotherapyClinical PsychologyTreatment OutcomeClinical researchFemalePsychology030217 neurology & neurosurgeryCut-pointClinical psychologyClinical Psychology & Psychotherapy
researchProduct

Can a meditation app help my sleep? A cross-sectional survey of Calm users

2021

Use of mindfulness mobile apps has become popular, however, there is little information about subscribers’ perceptions of app content and its impact on sleep and mental health. The purpose of this study was to survey subscribers to Calm, a popular mindfulness meditation app, to explore perceived improvements in sleep and mental health, evaluate what components of the app were associated with improvements in sleep and mental health, and determine whether improvements differed based on sleep quality. Calm subscribers who had used a sleep-related component in the last 90 days completed a Web-based investigator-developed survey and the Pittsburgh Sleep Quality Index. The survey included questio…

AdultMaleSleep Wake DisordersMindfulnessGeneral Science & TechnologySciencemedia_common.quotation_subjectAnxietyPittsburgh Sleep Quality IndexClinical ResearchBehavioral and Social ScienceComplementary and Integrative HealthmedicineHumansMeditationDepression (differential diagnoses)media_commonSleep disorderMultidisciplinaryDepressionQRMiddle Agedmedicine.diseaseMobile ApplicationsMental healthSleep in non-human animalsBrain DisordersCross-Sectional StudiesMeditationMental HealthMedicineAnxietyFemalemedicine.symptomSleep ResearchSleepPsychologyMind and BodyMindfulnessResearch ArticleClinical psychologyPLOS ONE
researchProduct

Diabetic Microagiopathy of Oral Mucosa Depends on Disease Duration and Therapy

2017

Background: Diabetes mellitus is a chronic degenerative systemic disease whose prevalence is increasing. This paper aims to evaluate the effects of diabetic microangiopathy, depending on its duration and the type of treatment administered, by using polarized light videocapillaroscopy of the oral mucosa. Material/Methods: We enrolled 120 subjects: 60 healthy subjects and 60 patients with diabetes mellitus. In turn, patients were divided into 3 subgroups according to the type of diabetes, the duration of the disease, and the type of treatment administered. A videocapillaroscopic examination of the oral mucosa was carried out on the diabetic and healthy subjects. Results: Changes in microcircu…

AdultMaleSystemic diseasemedicine.medical_specialtymedicine.medical_treatment030209 endocrinology & metabolismGastroenterologyMicroscopic AngioscopyMicrocirculationDiabetes Complications03 medical and health sciences0302 clinical medicineTongueClinical ResearchTongueDiabetes mellitusInternal medicinemedicineHumansOral mucosaType 1 diabetesbusiness.industryMicrocirculationInsulinMouth Mucosa030206 dentistryGeneral MedicineBuccal administrationMiddle Agedmedicine.diseaseCapillariesDiabetes Mellitus Type 1medicine.anatomical_structureDiabetes Mellitus Type 2Dentistry Diabetes Complications Microcirculation Microscopic AngioscopyDentistryFemalebusinessDiabetic AngiopathiesMedical Science Monitor
researchProduct

The Vaccination Concerns in COVID-19 Scale (VaCCS) : Development and validation

2022

Vaccines are highly effective in minimizing serious cases of COVID-19 and pivotal to managing the COVID-19 pandemic. Despite widespread availability, vaccination rates fall short of levels required to bring about widespread immunity, with low rates attributed to vaccine hesitancy. It is therefore important to identify the beliefs and concerns associated with vaccine intentions and uptake. The present study aimed to develop and validate, using the AMEE Guide, the Vaccination Concerns in COVID-19 Scale (VaCCS), a comprehensive measure of beliefs and concerns with respect to COVID-19 vaccines. In the scale development phase, samples of Australian (N = 53) and USA (N = 48) residents completed a…

AdultMaleand promotion of well-beingCOVID-19 VaccinesAdolescentGeneral Science & TechnologyVaccine RelatedYoung AdultClinical ResearchBehavioral and Social ScienceHumansterveyskäsityksetPreventionrokotteetAustraliaCOVID-19StatisticalMiddle AgedPrevention of disease and conditionsUnited StatesGood Health and Well Being3.4 VaccinesterveyskäyttäytyminenFemaleImmunizationVaccination HesitancyInfectionFactor AnalysisMind and Bodyrokotevastaisuus
researchProduct

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease

2019

Abstract Context Scarce data exist regarding the relevance of stimulatory (TSAb) and blocking (TBAb) thyrotropin receptor antibodies in the management of Graves disease (GD). Objective To evaluate the clinical utility and predictive value of TSAb/TBAb. Design Prospective 2-year trial. Setting Academic tertiary referral center. Patients One hundred consecutive, untreated, hyperthyroid GD patients. Methods TSAb was reported as percentage of specimen-to-reference ratio (SRR) (cutoff SRR < 140%). Blocking activity was defined as percent inhibition of luciferase expression relative to induction with bovine thyrotropin (TSH, thyroid stimulating hormone) alone (cutoff > 40% inhibitio…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' diseaseClinical BiochemistryThyrotropinContext (language use)dilution analysisBiochemistryGastroenterologyThyrotropin receptorThyroid binding inhibitory immunoglobulinsYoung AdultMethimazoleEndocrinologyTSH-R stimulating antibodiesInternal medicineGraves hyperthyroidismmedicineHumansprospective trialProspective StudiesAutoantibodiesClinical Research Articlebiologybusiness.industryBiochemistry (medical)Receptors ThyrotropinMiddle AgedPrognosismedicine.diseaseeye diseasesGraves DiseaseTSH-R blocking antibodiesTiterEndocrinologyProspective trialbiology.proteinFemaleAntibodybusinessBiomarkersAcademicSubjects/MED00250Follow-Up Studiesmedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Sexuality in autism: hypersexual and paraphilic behavior in women and men with high-functioning autism spectrum disorder

2017

Like nonaffected adults, individuals with autism spectrum disorders (ASDs) show the entire range of sexual behaviors. However, due to the core symptoms of the disorder spectrum, including deficits in social skills, sensory hypo- and hypersensitivities, and repetitive behaviors, some ASD individuals might develop quantitatively above-average or nonnormative sexual behaviors and interests. After reviewing the relevant literature on sexuality in high-functioning ASD individuals, we present novel findings on the frequency of normal sexual behaviors and those about the assessment of hypersexual and paraphilic fantasies and behaviors in ASD individuals from our own study. Individuals with ASD see…

AdultMalehypersexual disordergenetic structuresAutism Spectrum DisorderautismHuman sexualityparaphiliabehavioral disciplines and activities03 medical and health sciences0302 clinical medicineClinical ResearchAsperger syndromeparaphilic disorderSurveys and Questionnairesmental disordersmedicineHumans0501 psychology and cognitive sciencesSpectrum disorderChi-Square DistributionhypersexualityParaphilic Disorders05 social sciencesMiddle Agedmedicine.diseasesexualityHigh-functioning autismAsperger syndromeHypersexual disorderAutismFemaleHypersexualityParaphiliamedicine.symptomPsychology030217 neurology & neurosurgery050104 developmental & child psychologyClinical psychologyDialogues in Clinical Neuroscience
researchProduct